Wobble Genomics, a biotechnology company specialising in improving ... San Antonio Breast Cancer Symposium (SABCS), held on December 9-12 in ...
News
- Wobble Genomics shares new data confirming ability to determine profiling of HER2 in ...
- Marengo to Present Initial Results from Invikafusp Alfa and TRODELVY® Combination Study ...
... breaking presentation at the 2025 San Antonio Breast Cancer Symposium (SABCS) taking place December 9-12.
- Cleveland Clinic Presents Final Results of Phase 1 Clinical Trial of Preventive Breast ...
The findings, which will inform the subsequent Phase 2 study, are being presented at the San Antonio Breast Cancer Symposium. “Triple-negative ...
- Marengo to Present Initial Results from Invikafusp Alfa and TRODELVY® Combination Study ...
Marengo to Present Initial Results from Invikafusp Alfa and TRODELVY® Combination Study, STARt-002, at the 2025 San Antonio Breast Cancer Symposium.
- San Antonio City Council approves construction of new $15 million veterinary hospital | TPR
Bioscience-Medicine · Border & Immigration · Economy ... San Antonio City Council approves construction of new $15 million veterinary hospital.